MedTrace Logo

Nitric Oxide to Treat Pulmonary Embolism

NCT01939301 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2018-10-03

Study results available
· View outcomes & findings →

Summary

This is a randomized study to treat subjects diagnosed with pulmonary embolism with inhaled nitric oxide or placebo (oxygen).

Conditions

Interventions

DRUG

Inhaled Nitric Oxide

Nitric Oxide + oxygen

DRUG

Sham

Nitrogen + Oxygen

Sponsors & Collaborators

  • Mallinckrodt

    collaborator INDUSTRY

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of Mississippi Medical Center

    collaborator OTHER

  • University of Texas, Southwestern Medical Center at Dallas

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Indiana University School of Medicine

    lead OTHER

Principal Investigators

  • Jeff A Kline, MD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01939301 on ClinicalTrials.gov